tiprankstipranks
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC

Cyclacel Pharmaceuticals (CYCC) Stock Investors

606 Followers
Based on 727,813 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CYCC
On average, investors allocate 0.00% of their portfolios to CYCC
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CYCC

1.9%
Last 7
Days
11.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CYCC, out of 727,813 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CYCC Investor Activity

No data currently available
Based on the activity of 13,673 investors who made their portfolios public
The table shows changes in CYCC in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CYCC Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.13%
-0.77%
-3.02%
39.38B
Consumer Cyclical
Coherus Biosciences
2.66%
-2.17%
-7.98%
268.39M
Healthcare
Delta Air Lines
5.53%
+0.63%
-1.61%
30.74B
Industrials
Marathon Digital Holdings
5.48%
-0.46%
-3.07%
4.97B
Financial
Riot Platforms
4.87%
-0.06%
+1.79%
2.47B
Financial
GE Aerospace
5.49%
+1.87%
+5.04%
172.39B
Industrials
Assertio Therapeutics
2.63%
-1.88%
-9.24%
83.81M
Healthcare
ChargePoint Holdings
3.92%
-1.35%
-7.38%
698.54M
Consumer Cyclical
AMC Entertainment
5.39%
-1.74%
-7.04%
738.09M
Communication Services
Salesforce
4.96%
+0.95%
-1.83%
290.18B
Technology
Based on the activity of 727,813 active portfolios
Open your Smart Portfolio

CYCC Investor Analysis

CYCC investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
3.4%
of CYCC holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
CYCC investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
34.8%
of CYCC holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
CYCC investors over 55

Over 55

4.8%
Last 30 days
Holdings Change
61.8%
of CYCC holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of CYCC stock investors
See who invests in CYCC according to age group and performance.

FAQ

How many retail Investors hold CYCC?
<0.1% of TipRanks' retail investors hold CYCC in their portfolios.
    What is CYCC Investor Sentiment?
    CYCC’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CYCC in the last 7 days?
      ▼ 1.9% of TipRanks' retail investors changed their holding of CYCC in the last 7 days.
        What percentage of retail investors changed their holding of CYCC in the last 30 days?
        ▼ 11.8% of TipRanks' retail investors changed their holding of CYCC in the last 30 days.
          What is the average age of retail investors who hold CYCC?
          The average age of CYCC Holders is over 55.
            What other stocks have CYCC investors also bought?
            CYCC Investors also bought DKNG, CHRS, DAL, MARA, RIOT, GE, ASRT, CHPT, AMC, CRM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis